Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

TELA

$1.18+8.26%website ↗⬇ financials (.py)

TELA Bio, Inc.

Market Cap
$37M
As-of date unknown
Sector
Health Care
Industry
Health Care
Beta (raw)
1.34
60mo monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.9x
buying
Congress
—
recent trades
Short Volume
39%
W/W +15.0pp

Market & Alt Data

News
15
recent articles
Activist
13D
EW
Analyst Consensus
Strong Buy
11 analysts
Velocity Score
24.85x
Current Rate (90d)
1138.89/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
2
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-09-152026-09-16Capper Joseph HDirectorPurchase50.0K$1.06$53K104.8KView
2026-09-142026-09-16Capper Joseph HDirectorPurchase25.0K$1.02$26K54.8KView
2026-08-172026-08-19Getz Heather CDirector & Chief Executive OfficerPurchase12.5K$0.66$8K532.5KView
2026-08-142026-08-17Getz Heather CDirector & Chief Executive OfficerPurchase15.0K$0.70$10K520.0KView

Recent News

Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition
Yahoo Finance · 2026-09-14
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
Yahoo · 2026-08-31
TELA Bio Announces $17M Annual Expense Reduction Through 20% Workforce Streamlining and Resource Optimization, Extending Cash Runway Into 2028
Benzinga · 2026-08-31
TELA Bio COO And CFO Roberto Cuca To Step Down Effective Immediately
Benzinga · 2026-08-31

Informational purposes only, not investment advice.

TELA Bio, Inc. (TELA)

tormere.com/research/TELA · generated 2026-09-17

$1.18
+8.26%
General Information
Price$1.18
Change+8.26%
Market Cap$37M
SectorHealth Care
IndustryHealth Care
ExchangeNasdaq
Beta (raw, 60mo vs SPY)1.34
Signals
Insider Velocity24.9x buying
Congress Trades—
TELA Bio (TELA) Q2 2026 Earnings Call Transcript
Yahoo · 2026-08-19
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...
Yahoo Finance · 2026-08-11
TELA Bio Reports Second Quarter 2026 Financial Results
Yahoo Finance · 2026-08-10
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · 2026-08-05
Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.
Yahoo Finance · 2026-08-05
Teladoc (TDOC) Stock Plummets on Disappointing Q2 Earnings Results
Yahoo Finance · 2026-07-30
🔎 Under the Radar: Teladoc Shares Tumble on Therapist Shortage
Yahoo Finance · 2026-07-30
Teladoc Health Q2 Earnings Call Highlights
Yahoo Finance · 2026-07-30
Stocks making the biggest moves premarket: Meta, Microsoft, Teladoc, Norwegian Cruise Line & more
CNBC · 2026-07-30
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
Yahoo Finance · 2026-07-29
TELA Bio to Announce Second Quarter 2026 Financial Results
Yahoo Finance · 2026-07-20
Short Volume
39% of daily vol
Conviction Score54/100
Analyst ConsensusSB 3 · B 6 · H 2 · S 0 · SS 0
Price Chart (1 Year)
2025-09-172026-09-16$1.62$0.56
Recent Insider Activity (Form 4) — Last 5
DateInsiderTypeSharesValue
2026-09-15Capper Joseph HP50,000$52,940
2026-09-14Capper Joseph HP25,000$25,502.5
2026-08-17Getz Heather CP12,500$8,311.25
2026-08-14Getz Heather CP15,000$10,467
Recent News
  • Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition — Yahoo Finance · 2026-09-14
  • TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative — Yahoo · 2026-08-31
  • TELA Bio Announces $17M Annual Expense Reduction Through 20% Workforce Streamlining and Resource Optimization, Extending Cash Runway Into 2028 — Benzinga · 2026-08-31
  • TELA Bio COO And CFO Roberto Cuca To Step Down Effective Immediately — Benzinga · 2026-08-31
  • TELA Bio (TELA) Q2 2026 Earnings Call Transcript — Yahoo · 2026-08-19

Tormere — informational purposes only, not investment advice.

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Active
4 active trials · readout 2027-03